PT Kalbe Farma Tbk. (KLBF)の価格はいくらですか

PT Kalbe Farma Tbk. (KLBF)の価格は$0.04784262です

PT Kalbe Farma Tbk. (KLBF)の時価総額は何ですか

PT Kalbe Farma Tbk. (KLBF)の時価総額は$2.16Bです

PT Kalbe Farma Tbk. (KLBF) の収益

PT Kalbe Farma Tbk., an Indonesian pharmaceutical leader, along with its subsidiaries, focuses on the development, manufacturing, and commercialization of pharmaceutical products across Indonesia. Its operations are structured into four primary divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution & Logistics. The company's diverse portfolio encompasses generic, branded, and licensed medications, including well-known names like Brainact, Cefspan, and Mycoral, which are supplied to hospitals, pharmacies, and various drugstores. Beyond prescription drugs, it offers non-prescription medicines, a range of energy and ready-to-drink beverages, dietary supplements, and other preventive health solutions. Kalbe Farma also produces specialized nutritional products tailored for all demographics, from infants to seniors, including expectant mothers and individuals with specific medical dietary needs. The firm extends contract services to other pharmaceutical companies, covering clinical study management, bioavailability/bioequivalence assessments, and analytical testing. Additionally, it provides animal health products and operates its own healthcare facilities, the Mitrasana Clinics. Its broad scope of activities further includes health screening, acting as an agent for biotechnology products, and the distribution of consumer items, medical devices, and cosmetics. The company also trades in medical and laboratory equipment and supplies, raw materials for pharmaceuticals, and consumables for hemodialysis therapy, in addition to offering advertising services. Founded in 1966, PT Kalbe Farma Tbk. is headquartered in Jakarta, Indonesia.

年	収益	変化
提供された日付のデータは十分ではありません。

年

収益

変化

提供された日付のデータは十分ではありません。

企業	収益	収益の差	国
Eli Lilly and Company LLY.US	$79.67B	-	US
Johnson & Johnson JNJ.US	$97.93B	-	US
AbbVie Inc. ABBV.US	$64.39B	-	US
Roche Holding AG RO.SW	$77.52B	-	CH
Merck & Co., Inc. MRK.US	$66.40B	-	US

企業

収益

収益の差

国